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Abstract
Vestibular schwannoma (VS) is associated with dizziness and vertigo during all stages of
treatment. This report describes a patient who presented with a one-year history of
intermittent motion sickness, dizziness, headache, imbalance, and nausea. MRI showed a right-
side VS in the cerebellopontine angle and internal auditory canal. The patient elected to
undergo Gamma Knife radiosurgery for treatment. Within two to three months, she continued
to experience recurring dizziness, vertigo, neck stiffness, and head pressure. She was referred
for neurotology evaluation, which led to a diagnosis of vestibular migraine (VM). Her vestibular
reflexes were intact. Subsequently, she was treated with diet modification and low-dose
venlafaxine. She reported dramatically improved dizziness and vertigo symptoms at six-month
follow-up. VM is a very common cause of dizziness that should always be included in the
differential diagnosis, even in VS patients.
Categories: Otolaryngology, Radiation Oncology, Neurosurgery
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Introduction
Vestibular schwannoma (VS) is a benign and typically unilateral tumor of the eighth cranial
nerve. As such, VS patients commonly present with hearing loss (68%-94%), tinnitus (30%-
83%), and vestibular dysfunction (49%-75%), manifesting as dizziness and/or vertigo [1,2].
Using cross-sectional data, Carlson et al. show that over 60% of subjects experience long-term
dizziness, with risk factors including female sex, older age, and pre-existing dizziness or
migraine [3]. A histologic study has shown that VS is associated with atrophy of the vestibular
ganglion, peripheral vestibular nerve branches, and vestibular neuroepithelia [4]. Therefore, it
is evident that VS can cause dizziness through direct damage to the vestibular nerves or
sensory epithelia.
Vestibular migraine (VM) is increasingly recognized as a common cause of dizziness and
vertigo, and diagnostic criteria have been adopted by the Bárány Society and International
Headache Society. VM is diagnosed based on having at least five episodes of vestibular
symptoms that last 5 minutes to 72 hours, a concurrent or past history of migraine with or
without aura, and one or more migrainous features in at least half of the vestibular episodes [5].
VM patients often report worsening of vertigo, imbalance, and disequilibrium with increased
physical activity and head movements [6]. In a recent epidemiological study in the United
States, 2.7% of the adult population was found to have VM [7].
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There are three main treatment modalities for VS: microsurgery, stereotactic radiosurgery
(SRS), and observation. Notably, SRS has been suggested as a highly effective and safe option
for treating small and medium-sized VS [8]. After surgery or SRS, patients can experience acute
vestibular symptoms, including vertigo, dizziness, and imbalance, that significantly impact
their quality of life [9,10]. While vestibular hypofunction is the likely cause in many cases, it is
always important to maintain a wide differential diagnosis. This report describes a unique VS
patient who had recurring dizziness before and after SRS using Gamma Knife. She was
subsequently diagnosed with VM, which was successfully managed with diet modification and
migraine prophylactic medication.
Case Presentation
A 57-year-old woman initially presented with a one-year history of motion sickness and
headache. She also experienced intermittent nausea, dizziness, imbalance, clouded thinking,
fatigue, and head pressure. These symptoms often began within one hour of waking up in the
morning and could last up to four days. Although she previously attended vestibular physical
therapy, she had difficulty performing some of the exercises due to her sensitivity to positional
changes. She also had a history of chronic right neck stiffness, headaches with photophobia
during periods of nausea and dizziness, and occasional tinnitus and otalgia. She was otherwise
healthy, and followed a ketogenic diet and exercise program for weight control. She took the
following oral medications: dimenhydrinate 50 mg as needed for motion sickness, zolpidem 10
mg nightly, multivitamin daily, turmeric one capsule daily, magnesium 200 mg daily, and
calcium carbonate supplements with vitamin D 625 mg-125 IU twice daily. Her past surgical
history includes bunionectomy, coloscopy, and tonsillectomy. She smoked 1/4 pack of
cigarettes per day for 2.5 years during her adolescence and would consume 0.8 standard drinks
of alcohol per week. There was a family history of Alzheimer’s disease and heart disease. Her
review of symptoms was otherwise unremarkable.
During the initial visit with her primary care provider, the patient reported new nausea with a
sudden onset that would occasionally turn into a migraine headache with vertigo. She also
reported new mild dyspnea with exertion. As part of her workup, a MRI of her brain was
obtained, which showed an 11 x 12 x 9 mm homogeneously enhancing mass at the right
cerebellopontine angle and proximal internal auditory canal, suggestive of VS (Figure 1). An
audiogram showed normal hearing bilaterally with 100% word recognition score in both ears.
She was referred to neurosurgery for evaluation and was prescribed meclizine 25 mg by mouth
up to three times daily for dizziness and nausea.
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FIGURE 1: Pre-stereotactic radiosurgery MRI
Axial T1 post-contrast image shows a right-side cerebellopontine angle tumor measuring 11 x 12 x 9
mm.
After consideration of the three treatment modalities, she elected to undergo SRS using Gamma
Knife. She received 12.5 Gy dose to a target region 11 x 13 x 10 mm encompassing the right VS.
She tolerated the treatment well. About a month after SRS, she had recurring dizziness, vertigo,
neck stiffness, and head pressure. The dizziness was described as either a spinning sensation or
a sense of disequilibrium. She was prescribed diazepam 1 mg by mouth daily for symptomatic
relief, but it was not effective. She was also given a course of dexamethasone 2 mg by mouth
daily, but that also did not alleviate symptoms. She continued to experience dizziness, vertigo,
nausea, intermittent headaches with sensitivity to light and sound, and occasional sharp right
ear pain. She reported that these symptoms were affecting her mood as well. 
She was then referred to neurotology for evaluation. Examination of her head and neck did not
show any masses. Otomicroscopy was normal. Examination of cranial nerves, including extra-
ocular movements, facial movement and sensation, tongue and palate movement, and shoulder
shrug, was normal. A 512-Hertz tuning fork was used for the Weber test, which was midline
(normal), and the Rinne test, which showed air > bone conduction bilaterally (normal).
Vestibular function was assessed with the head impulse test, which was normal. She did not
have nystagmus or dizziness in the Dix Hallpike position. Cerebellar examination, including
finger to nose testing, rapid alternating movements, and heel to shin testing, was normal.
Romberg, with eyes open or closed and with feet together or tandem, showed normal balance. A
Timed Up and Go was completed in nine seconds (normal range) with normal gait. Post-
treatment audiogram showed no changes compared to baseline. 
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With her normal vestibular and cerebellar function, personal history of migraine without aura
per International Classification of Headache Disorders, Third Edition (ICHD-3) criteria, and
episodic vestibular symptoms associated with headache and light and sound sensitivity, the
patient was diagnosed with VM per Bárány Society criteria. Treatment options were discussed,
including both pharmacologic and non-pharmacologic paradigms. Due to the severity of
symptoms, she elected to do both. A standard handout was provided with recommendations on
migraine trigger avoidance, including stress reduction, sleep hygiene, and a migraine
elimination diet. The diet change was suggested to avoid any food triggers of her migraines. In
addition, medications were discussed with her, and she elected to try venlafaxine 37.5 mg by
mouth daily. At first, she reported feeling increased brain fog and head pressure after taking a
full tablet of venlafaxine. Therefore, her dose was adjusted to a half tablet.
In a follow-up visit three months later, she reported much improved symptoms. Her subjective
assessment was that she felt 90% better. She had been avoiding social activities and exercise,
which she was able resume after treatment of her VM. Occasionally, certain head movements or
positions, such as moving her head up and down, or the “downward dog” yoga position, could
trigger symptoms. Her post-SRS MRI showed no significant changes in the size of the right VS,
with development of a central necrosis (Figure 2). Further communication six months after
treatment showed continued dizziness relief with her treatment regimen.
FIGURE 2: Post-stereotactic radiosurgery (SRS) MRI
Axial T1 post-contrast image demonstrating the right vestibular schwannoma with a central
necrosis, after SRS using Gamma Knife.
Discussion
This report describes a patient treated with SRS using Gamma Knife for a VS, who had recurring
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dizziness, vertigo, neck stiffness, and head pressure. She was diagnosed and treated for VM,
which resulted in significant improvement in her symptoms.
Dizziness in VS patients is a commonly experienced symptom that could be related to a variety
of causes other than the tumor itself. In a retrospective cohort study on examining secondary
causes of vertigo in VS patients at a tertiary center, Sahyouni et al. found that 78% had
comorbid VM [11]. Therefore, it is imperative to evaluate dizziness in VS patients using a wide
differential diagnosis as part of their workup and treatment. The nature of symptoms should
also be clarified, as dizziness can be used non-specifically. For example, dizziness should be
distinguished from pre-syncope, orthostasis, and lightheadedness. Furthermore, many
medications can cause dizziness as a side effect. Table 1 summarizes the differential diagnosis
for dizziness and vertigo, along with treatment options for each specific diagnosis.
Diagnosis Diagnostic Clues Treatment Options
Vestibular migraine Motion intolerance on exam, light sensitivity




Oculomotor dysfunction, dysmetria, ataxia,
dysdiadochokinesia
Tumor removal, aminopyridines, vestibular
physical therapy
Hydrocephalus
Headache, vomiting, nausea, positional vertigo,




Oculomotor dysfunction, unilateral hearing loss,





Oculomotor dysfunction, unilateral hearing loss,
ataxia, facial weakness, Horner’s syndrome,





Vestibular testing (HIT, VNG, rotary chair testing) Vestibular physical therapy
Bilateral vestibular
hypofunction
Vestibular testing (HIT, VNG, rotary chair testing) Vestibular physical therapy
Benign paroxysmal
positional vertigo




CT scan, VEMP, audiometry





Patient history of disequilibrium (rocking and
swaying sensation)
Vestibular physical therapy, stress
reduction, SSRI
Ménière’s disease Audiometry and history
Low salt diet, oral steroids, diuretic,
vestibular physical therapy, intratympanic
steroids, intratympanic gentamicin
Surgical reinforcement of round and oval
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Perilymphatic fistula Audiometry, VNG, VEMP, history of trauma windows with tissue grafts
Persistent postural
perceptual dizziness
Chronic imbalance and dizziness, behavioral
assessments




Behavioral assessments, vestibular testing Per underlying condition
Vestibular
paroxysmia




HIT, postural instability, recurrent falls, vestibular
testing, gait disturbance
Vestibular physical therapy
TABLE 1: Differential diagnosis for dizziness in the setting of vestibular schwannoma
(VS).
The diagnosis, diagnostic clues, and treatment options are listed for distinct vestibular etiologies that should be considered for VS
patients experiencing dizziness and vertigo.
AICA, anterior inferior cerebellar artery; HIT, head impulse testing; PICA, posterior inferior cerebellar artery; SNRI, serotonin
norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor; VEMP, vestibular-evoked myogenic potential; VNG,
videonystagmography.
First, dangerous causes of dizziness must be ruled out. These include hydrocephalus and
cerebellar stroke, which can involve an acute onset of dizziness. VS patients with associated
hydrocephalus may present with headache, vomiting, nausea, positional vertigo, and MRI
showing effacement of the fourth ventricle and dilated lateral ventricles. Treatment options
include ventricular shunting and tumor removal. With anterior inferior cerebellar artery (AICA)
stroke, unilateral hearing loss, vestibular dysfunction, gait and limb ataxia, dysmetria, and
facial weakness are possible. Since branches of AICA supply the eighth cranial nerve, auditory
and vestibular dysfunction is widely reported [12]. With posterior inferior cerebellar artery
(PICA) stroke, vestibular dysfunction is usually observed, together with nausea, vomiting,
vertigo, dysmetria, and dysarthria. In both AICA and PICA stroke, direction-changing
nystagmus and severe ataxia are important clinical clues.
Cerebellar dysfunction, which can be caused by mass effect from the tumor, manifests as
dizziness and vertigo in 80% of chronic cases and 40%-60% in acute cases [13]. Physical exam
findings can include gaze-evoked nystagmus, saccadic dysmetria, and impaired vestibulo-
ocular reflex cancellation. In addition, patients with cerebellar dizziness and vertigo frequently
present with coordination problems, such as dysmetria and dysdiadochokinesia. Treatment of
cerebellar dysfunction associated with VS involves expeditious removal of the tumor. Post-
treatment cerebellar dysfunction involves consideration of physical therapy and
pharmacologic treatments, including aminopyridines, chlorzoxazone, and N-acetyl-DL-
leucine.
With vestibular hypofunction, asymmetries in vestibular afferents result in vertigo and
imbalance. This condition can be subdivided into static and fluctuating vestibular dysfunction.
With static dysfunction, vestibular physical therapy has been shown to be instrumental in
recovering loss of function [14]. Importantly, patients undergoing vestibular rehabilitation
should avoid vestibular suppressants and be physically active. For patients who are not
progressing with vestibular physical therapy, providers should assess vision, including
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stereoscopy, lower extremity sensation, and contralateral vestibular function. The latter is
particularly important to consider even before treatment intervention, as contralateral loss may
have implications for treatment decision making. This can be assessed at bedside using the
clinical head impulse test. With fluctuating vestibular dysfunction resistant to the
aforementioned treatments, it is worth considering ablative treatments, such as intratympanic
gentamicin for unilateral deafferentation of the vestibular system. While this procedure can be
done after SRS and for tumors being observed, formal vestibular testing should always be
performed in advance.
Additionally, vestibular hypofunction can occur unilaterally or bilaterally. Unilateral
hypofunction may arise from comorbid vestibular neuritis, VS, treatment for VS, Ménière’s
disease, and treatment for Ménière’s disease. Bilateral hypofunction may arise from damage to
the eighth cranial nerve due to neurofibromatosis type II, autoimmune diseases, trauma,
congenital problems, aminoglycoside antibiotics, idiopathic causes, superficial siderosis, and
CANVAS syndrome (cerebellar ataxia, neuropathy, vestibular areflexia). Although both types of
vestibular hypofunction involve the same diagnostic clues and treatment, patients with
bilateral hypofunction will often experience longer and more difficult vestibular physical
therapy.
Patients should also be evaluated for other common vestibular pathologies [15]. Benign
paroxysmal positional vertigo (BPPV) involves episodes of dizziness and spinning sensation
that last under a minute. The most common variant is posterior canal BPPV, which is treated
with the Epley maneuver. VM is another prevalent yet widely underdiagnosed vestibular
pathology [7]. Since there are no disease markers on exam or ancillary testing for VM, the
Bárány Society criteria are widely used to diagnose VM. Finally, rare causes of dizziness include
superior canal dehiscence syndrome, mal de debarquement syndrome, Ménière’s disease,
perilymphatic fistula, persistent postural perceptual dizziness, psychiatric causes of dizziness,
vestibular paroxysmia, and presbyvestibulopathy. Superior canal dehiscence syndrome can be
definitively diagnosed through a combination of CT scan, vestibular-evoked myogenic
potentials, audiometry testing, and characteristic symptoms, including pulsatile tinnitus,
autophony, and sound and/or pressure-induced dizziness. Treatment involves surgical plugging
or resurfacing of the dehiscent canal.
Dizziness is one of the most significant predictors of quality of life in VS patients [10,16,17].
Lee et al. report that 32% of VS patients developed vestibular dysfunction within six months of
SRS [18]. This highlights the importance of dizziness evaluation and treatment as part of the
comprehensive management of VS. A recent interventional study reports that all patients with
VS and comorbid VM had complete symptomatic resolution of their vertigo after being treated
with migraine prophylactic therapy (e.g., verapamil, topiramate, nortriptyline) and undergoing
migraine diet and lifestyle changes [11]. In a non-placebo randomized controlled trial, both
venlafaxine and propranolol were found to reduce vertigo episodes and severity in VM patients.
Venlafaxine additionally led to decreased depressive symptoms [6,19]. In a larger study of
subjects with migraine-associated dizziness, nortriptyline combined with dietary manipulation
(avoidance of processed cheese, meat, and red wines) was found to completely resolve or
reduce symptoms in 77% of subjects undergoing this treatment regimen [20]. This
improvement from a combined treatment of diet changes and migraine prophylactic
medication is consistent with the findings in our report.
Conclusions
This report highlights the significance of carefully evaluating dizziness using a wide differential
diagnosis in the setting of VS. Our patient was diagnosed with VM, and subsequent diet
modification along with pharmacologic treatment led to a significant reduction in symptoms.
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